Clinical Importance of estrogen reactivity in Hormone Receptor Positive HER2-Negative Breast Cancer

被引：0
|
作者：
Takeshita, Takashi [1 ]
Iwase, Hirotaka [1 ]
Takabe, Kazuaki [2 ]
机构：
[1] Kumamoto City Hosp, Kumamoto, Japan
[2] Roswell Pk Comprehens Canc Ctr, New York, NY USA
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1185
引用
收藏
页码：597 / 597
页数：1
相关论文
共 50 条
  • [21] Spatial interplay of lymphocytes and fibroblasts in estrogen receptor-positive HER2-negative breast cancer
    Nederlof, I
    Hajizadeh, S.
    Sobhani, F.
    Raza, S. E. A.
    AbdulJabbar, K.
    Harkes, R.
    van de Vijver, M. J.
    Salgado, R.
    Desmedt, C.
    Kok, M.
    Yuan, Y.
    Horlings, H. M.
    NPJ BREAST CANCER, 2022, 8 (01)
  • [22] The natural history of untreated estrogen receptor-positive, Her2-negative invasive breast cancer
    Rojas, Kristin E.
    Manasseh, Donna-Marie
    Rojas, Mary
    Mattocks, Andrea
    Portnow, Leah
    Kantharia, Sarah
    Zelenko, Natalie
    Giuliano, Christina
    Borgen, Patrick, I
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (01) : 79 - 83
  • [23] Clinical trial data and emerging immunotherapeutic strategies: hormone receptor-positive, HER2-negative breast cancer
    Kearney, Matthew R.
    McGuinness, Julia E.
    Kalinsky, Kevin
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (01) : 1 - 13
  • [24] Impact of clinical targeted sequencing on endocrine responsiveness in estrogen receptor-positive, HER2-negative metastatic breast cancer
    Hagio, Kanako
    Amano, Toraji
    Hayashi, Hideyuki
    Takeshita, Takashi
    Oshino, Tomohiro
    Kikuchi, Junko
    Ohhara, Yoshihito
    Yabe, Ichiro
    Kinoshita, Ichiro
    Nishihara, Hiroshi
    Yamashita, Hiroko
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [25] Impact of clinical targeted sequencing on endocrine responsiveness in estrogen receptor-positive, HER2-negative metastatic breast cancer
    Kanako Hagio
    Toraji Amano
    Hideyuki Hayashi
    Takashi Takeshita
    Tomohiro Oshino
    Junko Kikuchi
    Yoshihito Ohhara
    Ichiro Yabe
    Ichiro Kinoshita
    Hiroshi Nishihara
    Hiroko Yamashita
    Scientific Reports, 11
  • [26] Current Landscape of Targeted Therapy in Hormone Receptor-Positive and HER2-Negative Breast Cancer
    Andrahennadi, Samitha
    Sami, Amer
    Manna, Mita
    Pauls, Mehrnoosh
    Ahmed, Shahid
    CURRENT ONCOLOGY, 2021, 28 (03) : 1803 - 1822
  • [27] Sacituzumab-govitecan in hormone-receptor positive/HER2-negative advanced breast cancer
    Besnainou, Hanna
    Cabel, Luc
    BULLETIN DU CANCER, 2024, 111 (04) : 333 - 334
  • [28] Evolving treatment patterns in hormone receptor-positive, HER2-negative metastatic breast cancer
    Lankford, M. L.
    Britton, S. L.
    Buettner, A. D.
    Scharf, M.
    Tiscione, B.
    Willey, J. P.
    Mahtani, R. L.
    CANCER RESEARCH, 2019, 79 (04)
  • [29] Neoadjuvant tucidinostat combined with chemotherapy for hormone receptor-positive, HER2-negative breast cancer
    Niu, Nan
    Xue, Jinqi
    Qiu, Fang
    Chen, Guanglei
    Gu, Xi
    He, Guijin
    Cao, Shuo
    Yu, Xiaopeng
    Xu, Yongqing
    Yin, Jianqiao
    Han, Sijia
    Han, Ye
    Tang, Meiyue
    Zhao, Yafei
    Zheng, Ran
    Zheng, Xinyu
    Xu, Hong
    Liu, Caigang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
    Ditsch, Nina
    Schmidt, Marcus
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2019, 79 (12) : 1328 - 1335
12345